Please ensure Javascript is enabled for purposes of website accessibility
Inicio > Productos > Anticuerpos > Biosimilares

Anti-Human TNF-alpha Reference Antibody (Infliximab, RUO) (HF879036)

Anti-Human TNF-alpha Reference Antibody (Infliximab, RUO)
Anti-Human TNF-alpha Reference Antibody (Infliximab, RUO)
Anti-Human TNF-alpha Reference Antibody (Infliximab, RUO)
Anti-Human TNF-alpha Reference Antibody (Infliximab, RUO)
Anti-Human TNF-alpha Reference Antibody (Infliximab, RUO)
Anti-Human TNF-alpha Reference Antibody (Infliximab, RUO)
Anti-Human TNF-alpha Reference Antibody (Infliximab, RUO)
Anti-Human TNF-alpha Reference Antibody (Infliximab, RUO)
Anti-Human TNF-alpha Reference Antibody (Infliximab, RUO)
Anti-Human TNF-alpha Reference Antibody (Infliximab, RUO)
Precio(USD):
Especificación:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
Número:
Contáctenos
  • Vista general

  • Imágenes

  • Referencias

  • Datasheet

  • SDS

Vista general
Número de catálogoHF879036
Descripción
Infliximab (HF879036) is a research-grade recombinant antibody targeting CD2. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Reactividad de especiesHuman
AplicacionesELISA, Bioactivity: FCM, Functional assay, Research in vivo
Especie huéspedChimeric
ClonalidadMonoclonal
IsotipoIgG1, kappa
Aplicaciones probadas FCM
Objetivo C-domain 1, C-domain 2, Cachectin, ICD1, ICD2, Intracellular domain 1, Intracellular domain 2, N-terminal fragment, NTF, TNF, TNF-a, TNF-alpha, TNFA, TNFSF2, Tumor necrosis factor, Tumor necrosis factor ligand superfamily member 2, Tumor necrosis factor, membrane form, Tumor necrosis factor, soluble form
Nivel de endotoxinas < 10 EU/mg
Pureza >95% as determined by SDS-PAGE.
Purificación Protein A/G purified from cell culture supernatant.
Número de acceso P01375
Forma Liquid
Buffer de almacenamiento 0.01M PBS pH 7.4.

Consulte la información específica del buffer en la copia impresa del datasheet o en el COA específico del lote.

Estabilidad y almacenamiento Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Nombres alternativosTA-650, cA2, 170277-31-3
FondoOnercept is a recombinant soluble human tumor necrosis factor-alpha p55 receptor for use in Crohn's disease research.
Nota For research use only. Not suitable for clinical or therapeutic use.
Isotype Control Human IgG1 Recombinant Isotype Control Antibody (13R4) (HV080507)
Imágenes
  • Anti-Human TNF-alpha Reference Antibody (Infliximab, RUO)

    SEC-HPLC

    SEC-HPLC detection for Research Grade Infliximab.

  • Anti-Human TNF-alpha Reference Antibody (Infliximab, RUO)

    Bioactivity

    Detects Human TNFa/TNF-alpha in indirect ELISAs.

  • Anti-Human TNF-alpha Reference Antibody (Infliximab, RUO)

    SDS-PAGE

    SDS-PAGE for Anti-Human TNF-alpha Reference Antibody (Infliximab, RUO)

  • Anti-Human TNF-alpha Reference Antibody (Infliximab, RUO)

    Flow CytoMetry

    Flow-cytometry PE using anti-human TNFa antibody. Untransfected cells (blue Histogram) and Transfected cells (Yellow Histogram) were stained with an PE anti-human TNFa monoclonal antibody (Catalog: HF879036) at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.

  • Anti-Human TNF-alpha Reference Antibody (Infliximab, RUO)

    Flow CytoMetry

    Flow-cytometry using anti-human TNFa antibody. 293T Transtected cells were stained with an irrelevant antibody (Blue Histogram) or an anti-human TNFa monoclonal antibody (Catalog: HF879036, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, bound antibody was detected using a a Goat Anti-Human IgG H&L Polyclonal Antibody, FITC (abinScience: HF690414) and cells analysed on a NovoCyte Flow Cytometer.

Referencias
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recomendación

Contáctenos para cotizaciones personalizadas, solicitudes en masa y cualquier otro problema.

Correo: [email protected]

Lista de distribuidores